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Background: Infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae are the most
common bacterial sexually transmitted infections throughout the world. These sexually
transmitted infections are a growing problem in people living with HIV/AIDS. However, the
presence of these agents in extra genital sites, remains poorly studied in our country. The
objective of this study was to estimate the prevalence of Chlamydia trachomatis and Neisseria
gonorrhoeae anal and genital infection in people living with HIV/AIDS followed in a reference
center in Salvador, Brazil.
Methods: Cross-sectional study, from June 2013 to June 2015. Proven HIV-infected peo-
ple  attending this reference center were invited. Clinical and epidemiological data were
obtained through interview with standardized form. Chlamydia trachomatis and Neisseria
gonorrhoeae screening was performed using qPCR (COBAS 4800® Roche).
Results: The frequency of positive cases of Chlamydia trachomatis and Neisseria gonorrhoeae
was  12.3% in total, 9.2% cases amongst women and 17.1% amongst men. We found 14.0% of
positive cases in anus and 3.1% in genital region in men, while 5.6% and 3.6%, in women,
respectively. Among men, anal infection was associated with age <29 years (p = 0.033), reportof  anal intercourse (p = 0.029), pain during anal intercourse (p = 0.028). On the other hand,no  association between genital infection and other variables were detected in bivariate
analysis. Among women, we detected an association between Chlamydia trachomatis gen-
ital  infection and age <29 years (p < 0.001), younger age at ﬁrst sexual intercourse (p = 0.048),
pregnancy (p < 0.001), viral load >50 copies/mL (p = 0.020), and no antiretroviral use (p = 0.008).
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Anal infection in women was associated with age <29 years old (p < 0.001) and pregnancy
(p  = 0.023), and was not associated with report of anal intercourse (p = 0.485).
Conclusion: Missed opportunities for diagnosis in extra genital sites could impact on HIV
transmission. The extra genital sites need to be considered to break the HIV and bacterial
sexually transmitted infections chain-of-transmission.
© 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/Introduction
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
infections are the most common bacterial sexually transmit-
ted infections (STI) throughout the world.1 These infections
may cause complications both in men  and women, such
as epididymitis, urethritis, cervicitis, pelvic inﬂammatory
disease, and ectopic pregnancy.1,2 STI in extragenital sites,
such as anus, rectum, and pharynx, are an increasing cause
for concern. Recent studies show increasing reports of anal
intercourse amongst heterosexuals and lower rates of con-
dom use in anal intercourse compared to vaginal intercourse.3
Anorectal mucosa is vulnerable to HIV due to lack of appro-
priate protective humoral immune barrier and for being more
susceptible to traumatic lesions then the vaginal mucosa.4
In addition, possible biological, behavioral, and social factors,
such as insufﬁcient knowledge regarding anorectal STI risks
and anal intercourse to please the partner also contribute to
STI infection.5 The low percentage of diagnostic screening in
addition to inappropriate treatment maintain the bacterial
STI chain-of-transmission, thus increasing STI and HIV
transmission.6
The presence of CT and NG infection, especially in the
anorectal region, is associated to the increased risk of HIV
infection. In people living with HIV/AIDS (PLHA), CT and NG
infections increase the genital HIV viral load (VL) and the
possibility of sexual and vertical transmission of the virus.7
Despite the raise of the HIV epidemics amongst men  who have
sex with men  (MSM)  highlight the role of unprotected anal
intercourse on the HIV transmission, the role of this practice in
the heterosexual HIV transmission is still poorly understood.
Although studies show anorectal prevalence for CT in
women (6.6–9.3%) to be similar to that of MSM (6.5–10.1%) and
the therapeutic recommendations for infections on this site
possibly differ from those in the urogenital sites,6,8,9 there is
still no deﬁnition regarding the systematic investigation for
CT and NG in extragenital sites in heterosexual women.
The aim of this study was to estimate the prevalence of
anorectal and genital infection by C. trachomatis and Neisse-
ria gonorrhea and the associated risk factors, such as lifestyle
and sexual practices, in women and men  living with HIV/AIDS
receiving care in a reference center in Salvador, Brazil.
Material  and  methodsPatients  and  settings
This was a cross-sectional study conducted at Centro Espe-
cializado em Diagnóstico, Assistência e Pesquisa (CEDAP) fromlicenses/by-nc-nd/4.0/).
June 2013 to June 2015. CEDAP is the state reference center for
STI and HIV in Salvador, Bahia, Northeast of Brazil, attending
approximately 60% of PLHA in the state, with an average of 76
new cases of HIV/AIDS and 373 new cases of STI each month.
The health center is staffed with infectious disease specialists,
and other medical and paramedical professionals. Irrespective
of their area of specialization physicians are trained to deliver
care for patients with sexually transmitted diseases.
Conﬁrmed HIV-infected patients undergoing treatment
with the gynecologist and proctologist at the clinic were
invited to participate in the study, regardless of their signs
and symptoms of STI. Sexually active patients regardless of
age were assessed. Patients who had used antibiotics 30 days
before from the appointment, and women with genital bleed-
ing at the exam were not included. Pregnant women with
no recent obstetric complications were also included in this
study.
Laboratory  tests
The CT and NG screening was performed using qPCR in closed
system – In vitro Diagnostic (IVD), COBAS 4800® Roche, using
COBAS® PCR Media Female as transport for the endocervix
and anorectal specimens, and COBAS® PCR Media Urine for
male urine samples. The samples were collected according
to the manufacturer instructions. The anorectal samples col-
lection was adapted for COBAS® PCR Media Female, as it is
not standardized for the IVD from COBAS 4800® Roche sys-
tem. The anorectal samples were collected through the swab
introduced 2–3 cm after anal margin and it was done in 360◦
turn; endocervix samples were collected by gynecologist dur-
ing specular exam; and urine was collected by the patients
in adequate recipients. The samples were collected during a
medical appointment at CEDAP and were processed at the Pro-
fessor Gonc¸alo Moniz Central Laboratory of Public Health of
Bahia – LACEN-BA.
All patients had a blood sample drawn to assess HIV viral
load and TCD4+/TCD8+ cells count at the time of the appoint-
ment. Lymphocyte TCD4+/TCD8+ count was performed by
ﬂow cytometry (Facscalibur, Becton and Dickinson, California,
USA) and HIV viral load was quantiﬁed using PCR Real time
(Abbot molecular, Illinois, USA)
Data  collection
Socio-demographic, behavioral, and clinical data were
obtained through standardized medical interview. Patients
were scheduled further medical appointment one month
after sample collection for delivering tests results and
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rescribing treatment of the identiﬁed infections. All patients
igned a written informed consent. This study was approved
y the Ethics Committee of the Maternidade Climério de
liveira/Universidade Federal da Bahia (process 292,413).
tatistical  analyses
ata analysis were performed using SPSS 20.0 (SPSS Inc,
hicago, IL, USA). Chi-square test was used for univariate anal-
sis of categorical variables like ethnicity (white × non-white),
arital status (single × married/stable union), schooling (≤8
ears of study × >8 years of study), alcohol intake, tobacco and
rug use (yes × no). Continuous variables such as age, age at
rst intercourse, number of partners, and time since HIV diag-
osis were analyzed by Student’s t test. p-values lower than
.05 were considered statistically signiﬁcant; 95% conﬁdence
ntervals (CI) were calculated for means and proportions. Vari-
bles with p ≤ 0.20 in univariate analysis were included in the
ogistic regression backward stepwise model for multivariate
nalysis. For women, the variables in the regression were: age,
chooling, pregnancy, alcohol use, drugs use, pelvic pain, cer-
icitis, genital discharge, alcohol before sex, anal receptive
ntercourse, HAART use, HIV viral load. For men, those who
eferred no anal receptive intercourse were excluded from the
ogistic regression analysis because they did not have CT or
G anal infection. Therefore, the variables analyzed were: age,
thnicity, alcohol before sex, pain in anal intercourse, genital
lcer and painful anorectal exam.
esults total of 521 PLHA, 208 men  and 313 women were evaluated.
f those, 15 (2.9%) men  who did not collect a urine sample and
ight (2.6%) women who had inadequate anorectal samples
Table 1 – Clinical and socio-demographic characteristics of 498 
to gender.
Characteristics M
Age (years), mean (SD) 3
Age at sexual debut (years), mean (SD) 1
Lifetime number of sexual partners, median (IQR) 3
White race, n (%) 3
Married/cohabitating Marital status, n (%) 4
Educational level ≥8 years, n (%) 17
Monthly household income ≤2 minimum wages, n (%)a 10
Alcohol use, n (%) 14
Tobacco use, n (%) 4
Drug use, n (%) 5
Alcohol use before sex, n (%) 9
Drug use before sex, n (%) 3
Transactional sex, n (%) 1
Anal receptive intercourse, n (%) 16
Previous STI, n (%) 16
Time from HIV diagnosis (months, median (IQR) 4
ART in use, n (%) 15
Duration on ART (days), median (IQR) 2
STI, sexually transmitted infections.
The numbers do not always add up the total because of missing values.
a Minimum wage ≈$194.6;2 0(6):569–575 571
were excluded. There was no statistically signiﬁcant differ-
ence between the enrolled and excluded patients.
The ﬁnal sample comprised 305 women and 193 men.
The overall prevalence of any CT or NG infection was
12.3% (61/498), 9.2% (28/305) cases amongst women and
17.1% (33/193) amongst men. The overall mean age was 37.0
years (±10.5), 10.4% (52/498) self-reported to be white, 38.6%
(192/498) were married or in a common-law marriage, and
73.5% (366/498) had more  than eight years of regular educa-
tion. A total of 83.1% (414/498) were on antiretroviral therapy,
but 37.0% (165/446) had viral load above 40 copies/mL.
Some signiﬁcant differences between genders were found
in this study sample. Men were younger, mostly single, with
higher education and family income. Alcohol, tobacco and
drug use were more  frequently declared by men, as well as
higher number of sexual partners, receptive anal sex, and his-
tory of STI, as seen on Table 1.
Amongst women, there were seven cases of combined CT
infection (endocervix and anus). Two men  (6.1%) had both
anorectal and urine positive for NG infection, and one (3.0%)
for CT infection in both sites. Regarding the investigated site,
there were 14.0% (27/193) of positive cases in anus and 3.1%
(6/193) in genital region in men, while 5.6% (17/305) and 3.6%
(11/305) cases in women, respectively (Table 2).
Clinical, behavioral, and epidemiological aspects associ-
ated with the presence of CT and NG infection in genital
and anorectal areas in men  and women are described in
Table 3. Among men, anorectal infection was associated with
age <29 years (p = 0.033), report of anal intercourse (p = 0.029),
pain during anal intercourse (p = 0.028), and painful anorectal
exam (p = 0.022). Only men  who referred anal intercourse have
CT and NG anal infection. After logistic regression, the vari-
ables that remained signiﬁcantly associated with anorectal
infection were painful anorectal exam (p = 0.014, OR-3.59, 95%
CI 1.29–9.95), and white ethnicity (p = 0.018, OR-3.85, 95% CI
people living with HIV/AIDS, in Salvador, Brazil, according
en (n = 193) Women (n = 305) p-Value
5.8 (9.9) 37.7 (10.8) 0.042
4.9 (3.4) 16.4 (3.5) <0.001
0 (12–200) 5 (3–10) <0.001
0 (15.5) 22 (7.2) 0.003
6 (23.8) 159 (52.1) <0.001
0 (88.1) 196 (64.3) <0.001
2 (53.4) 252 (82.6) <0.001
4 (74.6) 166 (54.4) <0.001
2 (21.9) 29 (9.6) <0.001
2 (26.9) 43 (14.1) <0.001
1 (47.2) 123 (40.9) 0.169
2 (16.6) 23 (7.5) 0.002
9 (9.8) 28 (9.2) 0.805
7 (86.5) 191 (62.6) <0.001
7 (86.5) 151 (49.5) <0.001
2.5 (10.5–121.7) 85.2 (32.8–136.8) <0.001
9 (82.4) 255 (83.6) 0.722
4.3 (2.0–82.6) 48.7 (3.0–121.7) 0.004
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Table 2 – Prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in 498 people living with HIV/AIDS, in
Salvador, Brazil.
Chlamydia trachomatis
n/N (%)
Neisseria gonorrhoeae
n/N (%)
Totala n/N (%)
Male
Anus 18/193 (9.3) 11/193 (5.7) 27/193 (14.0)
Urine 3/193 (1.6) 3/193 (1.6) 6/193 (3.1)
Female
Anus 16/305 (5.3) 2/305 (0.7) 17/305 (5.6)
Endocervix 11/305 (3.6) 0/305 (0.0) 11/305 (3.6)a Excluded co-infections.
1.26–11.77). On the other hand, no association between genital
infection and other variables were detected in univariate anal-
ysis. After logistic regression, only lifetime sexual partners
>3 (p = 0.019, OR-22.41, 95% CI 1.67–305.94) was independently
associated with genital infection.
Among women, there was an association between CT
genital infection and age less than 29 years old (p < 0.001),
younger age at ﬁrst sexual intercourse (p = 0.048), school-
ing less than eight years (p = 0.020), pregnancy (p < 0.001),
viral load >50 copies/mL (p = 0.020), and no antiretroviral use
(p = 0.008). After logistic regression, age less than 29 years
old (p = 0.010, OR-8.25, 95% CI 1.67–40.76), schooling less than
eight years (p = 0.012, OR-8.29, 95% CI 1.61–42.77), pregnancy
(p = 0.002, OR-13.57, 95% CI 2.63–69.94), alcohol use before sex-
ual act (p = 0.025, OR-14.54, 95% CI 1.39–151.61), and cervicitis
(p = 0.056, OR-6.18, 95% CI 0.96–39.97) remained statistically
signiﬁcant.
Anorectal infection in women was associated with age
less than 29 years old (p < 0.001) and pregnancy (p = 0.023),
but it was neither associated with report of anal intercourse
(p = 0.485) nor presence of symptoms. Only age less than 29
years old (p = 0.001, OR-10.54, 95% CI 3.23–34.41) remained
associated with infection after logistic regression.
Discussion
A high prevalence of CT and NG infection in PLHA (12.3%) was
found in this study, which was higher among men  (17.7%) than
women (9.2%). Infections were more  prevalent in the anorectal
(8.8%) site than in the genital (3.8%) site. Nowadays, there is
an increase in anorectal STI, even among heterosexuals.3,9,10
Some guidelines recommend CT and NG screening in extra-
genital sites on MSM,  however it remains undeﬁned for
heterosexuals.11,12 Some authors suggest focusing the screen-
ing on women who report anal intercourse.10,13 The lack of
association between women reporting anal intercourse and
presence of anorectal infection in our study corroborate the
ﬁndings of a study conducted in Baltimore, 2014.14 The pres-
ence of bacterial infection with or without symptoms in anus
and rectum, the practice of anal intercourse in the general
population, and the increasing risk of HIV transmission rein-
force the need for appropriate STI diagnosis and treatment on
anorectal site. In this study, if the screening had been onlyurogenital, CT and NG infection diagnoses would have been
missed in 88.9% of cases in men  and 58.8% in women.
Amongst the women evaluated on this study, the asso-
ciation between anorectal and genital site of infection and
younger age (p < 0.001 on both cases) and pregnancy (p < 0.001
and p = 0.023) highlights the need for screening that population
during routine follow-up. These associations have been found
in studies with women living with HIV/AIDS, and in the gen-
eral population,15–17 but it is not yet a routine in most services
in Latin America. Recent studies detected a higher chance
of HIV vertical transmission on women co-infected with NG
or CT.18,19 A systematic CT and NG investigation for young
women, pregnant women, and women living with HIV/AIDS
can contribute to the reduction of HIV transmission, and be
an effective prevention measure.
In our study, the prevalence found on women’s anorectal
region was 5.3% for CT and 0.7% for NG; 29.4% of women with
infection in the anorectal region denied practice of anal inter-
course. There are few reports regarding the investigation of
this site in women who do not admit anal intercourse or symp-
toms on the anal region.10 The prevalence rates described in
women with this practice vary between 8.6%–12.7% for CT and
1.0%–2.9% for NG on anorectal sites.6,14,20 We found an associ-
ation between presence of infection in cervix and in anorectal
site, similar to other authors.13 Some studies highlight the
possibility of self-inoculation or “translocation” of genital site
infection.14,21 Our study underscores the need for investi-
gating the anorectal site in women living with HIV/AIDS,
regardless of anal intercourse practice.
We found a high rate of anorectal site infection among men
(14.0% positive cases, 9.3% for CT and 5.7% for NG), similar
to the CT and NG prevalence found in other studies in Brazil
(10.0% and 2.5%), USA (7.9% and 6.9%), Netherlands (10.1% and
5.5%), and Russia (7.3% and 2.0%).6,22–24 Only men  who  referred
anal intercourse have CT and NG anal infection. The char-
acteristics of this population are similar to those studied in
other countries, with multiple sexual partners, receptive and
insertive anal intercourse, higher education/socioeconomic
situation. Despite the access to information on STI prevention,
the high prevalence indicates a high exposure to NG and CT.
These points toward an urgent need for reinforcing preventive
measures, such as condom use, education on sexual transmis-
sion risk, and prompt access to bacterial and HIV infections
post-exposure prophylaxis.
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Table 3 – Univariate analysis of sociodemographic, clinical and sexual behavior-related risk factors for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
infection in 498 people living with HIV, in Salvador, Brazil.
Men Women
Urogenital CT/NG (n = 6) Anorectal CT/NG (n = 27) Endocervical CT/NG (n = 11) Anorectal CT/NG (n = 17)
n (%) p  OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI
Socio-demographic
Age ≤29 years old 2 (3.8) .669 1.32 0.24–7.45 12 (22.6) .023 2.61 1.12–6.10 8 (10.8) .001 9.21 2.38–35.71 11 (14.9) .000 6.55 6.33–18.40
Single 4 (2.7) .652 0.62 0.12–3.31 21 (14.3) .832 1.11 0.42–2.95 5 (3.1) .630 0.76 0.23–2.54 11 (6.9) .285 1.73 0.63–4.82
White ethnicity 2 (6.7) .235 2.84 0.50–16.25 7 (23.3) .108 2.18 0.82–5.72 1 (4.5) .567 1.30 0.16–10.65 3 (13.6) .114 3.03 0.80–11.48
Less than 8 schooling years 0 (0.0) 1.000 1.04 1.01–1.07 2 (8.7) .748 0.55 0.12–2.50 8 (7.3) .020 5.10 1.32–19.63 7 (6.4) .630 1.27 0.47–3.46
Monthly income ≤2 MWa 3 (2.9) 1.000 0.87 0.17–4.42 15 (14.7) .809 1.11 0.49–2.51 11 (4.4) .222 0.96 0.93–0.98 14 (5.6) 1.000 0.98 0.27–3.54
Pregnant women – – 6 (18.8) .000 12.37 3.53–43.31 5 (15.6) .023 4.03 1.32–12.30
Alcohol use 5 (3.5) 1.000 1.73 0.20–15.15 22 (15.3) .376 1.59 0.57–4.45 3 (1.8) .120 0.30 0.08–1.16 8 (4.8) .530 0.73 0.27–1.95
Tobacco use 2 (4.8) .614 1.83 0.32–10.33 6 (14.3) .962 1.02 0.39–2.73 0 (0.0) .608 1.04 1.02–1.07 1 (3.4) 1.000 0.58 0.07–4.51
Drug use 2 (3.8) .661 1.37 0.24–7.71 9 (17.3) .420 1.43 0.60–3.42 3 (7.0) .191 2.38 0.60–9.35 1 (2.3) .483 0.37 0.05–2.83
Sex-risk behaviors
Lifetime sexual partners >3 2 (66.6) .092 18.20 1.41–235.34 2 (66.6) .370 3.10 0.27–35-38 6 (3.0) .409 1.66 0.50–5.57 9 (4.5) .237 1.80 0.67–4.80
Irregular condom use 2 (4.8) .614 1.83 0.32–10.32 7 (16.7) .583 1.30 0.51–3.32 3 (3.0) 1.000 0.75 0.19–2.88 3 (3.0) .194 0.41 0.12–1.47
Alcohol before sex 3 (3.3) 1.000 1.13 0.22–5.72 17 (18.7) .076 2.11 0.91–4.89 1 (0.8) .031 0.14 0.02–1.09 6 (4.9) .631 0.78 0.28–2.16
Drug before sex 1 (3.1) 1.000 1.01 0.11–8.92 4 (12.5) 1.000 0.86 0.28–2.67 1 (4.3) .584 1.24 0.15–10.11 1 (4.3) 1.000 0.76 0.10–5.97
Transactional sex 0 (0.0) 1.000 1.04 1.01–1.07 2 (10.5) 1.000 0.70 0.15–3.22 2 (7.2) .267 2.29 0.47–11.17 1 (3.6) 1.000 0.60 0.08–4.73
Anal receptive intercourse 5 (3.0) .585 0.77 0.09–6.88 27 (16.2) .029 0.84 0.78–0.90 4 (2.1) .108 0.33 0.09–1.14 12 (6.3) .485 1.46 0.50–4.26
Previous STI 6 (3.6) 1.000 0.96 0.94–0.99 26 (15.6) .136 4.61 0.60–35.53 6 (4.0) .734 1.23 0.39–4.13 6 (4.0) .228 0.54 0.19–1.49
Patient complaints
Anal ﬁssureb 2 (3.4) 1.000 1.12 0.20–6.31 10 (16.9) .456 1.38 0.59–3.23 – –
Pain in anal intercourse 2 (4.0) .676 1.28 0.23–7.23 12 (24.0) .028 2.55 1.09–5.99 – –
Dyspareunia – – 3 (4.5) .706 1.36 0.33–5.62 5 (7.6) .696 1.24 0.42–3.73
Genital discharge 1 (16.7) .178 7.12 0.70–72.72 1 (16.7) .594 1.26 0.14–11.27 6 (5.5) .188 2.21 0.66–7.43 9 (8.3) .131 2.10 0.79–5.62
Genital ulcer 1 (4.0) .570 1.36 0.15–12.13 6 (24.0) .122 2.21 0.79–6.16 0 (0.0) 1.000 1.04 1.02–1.06 0 (0.0) .610 1.06 1.03–1.09
Pelvic pain 0 (0.0) 1.000 0.58 0.07–4.66 3 (17.6) .713 1.35 0.36–5.04 6 (5.5) .188 0.58 0.18–1.85 4 (3.7) .313 0.53 0.17–1.68
Anal pain 2 (2.6) 1.000 0.74 0.13–4.14 14 (18.2) .179 1.74 0.77–3.95 0 (0.0) 1.000 1.04 1.02–1.07 0 (0.0) .614 1.06 1.03–1.09
Clinical ﬁndings
Anal ﬁssureb 1 (1.6) .666 0.38 0.04–3.36 9 (14.1) .914 1.05 0.44–2.51 – –
Genital discharge 1 (20.0) .148 9.15 0.86–97.35 1 (20.0) .533 1.56 0.17–14.49 5 (4.7) .463 1.57 0.47–5.26 6 (5.6) .985 1.01 0.36–2.81
Urethritis 1 (16.7) .175 7.28 0.71–74.35 1 (16.7) 1.000 1.24 0.14–11.03 – –
Cervicitis – – 3 (13.6) .037 5.43 1.33–22.14 3 (13.6) .114 3.03 0.80–11.48
Painful anorectal examb 0 (0.0) .585 1.04 1.00–1.07 9 (25.0) .022 2.88 1.13–7.34 – –
Painful bimanual exam – – 2 (7.7) .270 2.28 0.47–11.15 0 (0.0) .382 1.07 1.04–1.11
Viral load .650 2.52 0.27–23.03 .626 0.79 0.31–2.01 .020 0.20 0.05–0.78 .051 0.36 0.12–1.04
≤40 cp/mL 4 (4.0) 12 (11.9) 3 (1.7) 6 (3.3)
>40 cp/mL 1 (1.6) 9 (14.5) 8 (7.8) 9 (7.8)
CD4+ ≤500 cells/L 1 (1.7) .653 0.42 0.05–3.84 10 (16.7) .271 1.67 0.66–4.21 3 (3.6) 1.000 0.92 0.24–3.55 7 (8.4) .178 1.99 0.72–5.55
No ART in use 1 (2.94) 1.000 1.07 0.12–9.48 5 (14.7) .894 0.93 0.33–2.66 5 (10.0) .008 0.22 0.06–0.74 5 (10.0) .136 0.44 0.15–1.32
CT/NG indicates chlamydia and/or gonorrhea infection.
a MW,  minimum wage ≈$194.
b Investigation on anal ﬁssure and painful anorectal exam were only performed by the proctologist in male patients.
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Antiretroviral therapy (ART), HIV viral suppression and
improved immune status did not protect against STI infec-
tion in urogenital or anal sites in male patients of our study.
The available evidence on these factors are controversial:
some authors detected more  infections in patients with higher
TCD4+ cell counts,25 but Cunha et al. did not ﬁnd such
association.22 Some studies have shown an increased trans-
mission of HIV in men  or women infected by a bacterial STI,
possibly due to the immune activation that increases expres-
sion of CCR5 receptors on mucosa and genital viral load.7,26,27
Receptive unprotected anal sex represents risk of HIV trans-
mission of 5–18 times higher on each sexual act.28,29 The sense
of protection currently publicized by the use of ART cannot be
extended to the STIs on the population of men  living with HIV.
This study has limitations: an interview was conducted
face to face, leading to some degree of inhibition by the
respondents, especially as to sexual practices. The popula-
tion included in the study attends the service and, therefore,
has access to care and guidance. There is no such data on
HIV-negative people, or on those who  do not attend special-
ized health centers. PLHA, is a population with increased
prevalence of other STIs, and we  have to be cautions when
extrapolating these ﬁndings to the general population. Deﬁn-
ing who  is the heterosexual population who  needs screening
for infection in extragenital sites still requires more  epidemi-
ological and cost-effectiveness studies.
The “Treat as Prevention” strategy adopted in 2013 by
Health Ministry of Brazil30 and in 2015 by the WHO,  intends to
reduce HIV sexual transmission through increasing virological
suppression. The impact of this policy on bacterial STIs trans-
mission, such as syphilis, CT, and NG in PLHA is unknown.
The increase of unprotected sex due to the possibility of not
occurring sexual transmission of HIV could lead to an increase
of these STIs. This may be a limitation to the future success
of the “Treat as Prevention” strategy. Training of health pro-
fessionals, access to early diagnosis and treatment of STIs,
educational interventions on sexual practices, risk manage-
ment, and prevention along with the population, especially
PLHA and key populations, are essential measures to end the
HIV epidemic, the global goal for 2030, and break bacterial STI
chain-of-transmission.
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